146 related articles for article (PubMed ID: 2891081)
1. Feedback inhibition of opioid peptide release in the hypothalamus of the rat.
Nikolarakis KE; Almeida OF; Herz A
Neuroscience; 1987 Oct; 23(1):143-8. PubMed ID: 2891081
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (in vitro).
Nikolarakis KE; Almeida OF; Herz A
Brain Res; 1986 Dec; 399(1):152-5. PubMed ID: 2879612
[TBL] [Abstract][Full Text] [Related]
3. Regulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (CRF).
Almeida OF; Nikolarakis KE; Herz A
NIDA Res Monogr; 1986; 75():401-2. PubMed ID: 2893273
[TBL] [Abstract][Full Text] [Related]
4. Prolonged inflammatory pain modifies corticotropin-releasing factor-induced opioid peptide release in the hypothalamus.
Shippenberg TS; Herz A; Nikolarakis K
Brain Res; 1991 Nov; 563(1-2):209-14. PubMed ID: 1686211
[TBL] [Abstract][Full Text] [Related]
5. Significance of testosterone in regulating hypothalamic content and in vitro release of beta-endorphin and dynorphin.
Almeida OF; Nikolarakis KE; Herz A
J Neurochem; 1987 Sep; 49(3):742-7. PubMed ID: 2886553
[TBL] [Abstract][Full Text] [Related]
6. Effects of opioid peptides on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro.
Yajima F; Suda T; Tomori N; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
Life Sci; 1986 Jul; 39(2):181-6. PubMed ID: 2873496
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of hypothalamic opioid peptide release by lithium is mediated by opioid autoreceptors: evidence from a combined in vitro, ex vivo study.
Burns G; Herz A; Nikolarakis KE
Neuroscience; 1990; 36(3):691-7. PubMed ID: 2172862
[TBL] [Abstract][Full Text] [Related]
8. Concomitant changes in the in vitro and in vivo release of opioid peptides and luteinizing hormone-releasing hormone from the hypothalamus following blockade of receptors for corticotropin-releasing factor.
Nikolarakis KE; Almeida OF; Sirinathsinghji DJ; Herz A
Neuroendocrinology; 1988 Jun; 47(6):545-50. PubMed ID: 2840600
[TBL] [Abstract][Full Text] [Related]
9. Presynaptic auto- and allelo-receptor regulation of hypothalamic opioid peptide release.
Nikolarakis KE; Almeida OF; Yassouridis A; Herz A
Neuroscience; 1989; 31(1):269-73. PubMed ID: 2570378
[TBL] [Abstract][Full Text] [Related]
10. Pre- and postsynaptic actions of GABA on the release of hypothalamic gonadotropin-releasing hormone (GnRH).
Nikolarakis KE; Loeffler JP; Almeida OF; Herz A
Brain Res Bull; 1988 Oct; 21(4):677-83. PubMed ID: 3061570
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing factor stimulates the release of methionine-enkephalin and dynorphin from the neostriatum and globus pallidus of the rat: in vitro and in vivo studies.
Sirinathsinghji DJ; Nikolarakis KE; Herz A
Brain Res; 1989 Jun; 490(2):276-91. PubMed ID: 2569903
[TBL] [Abstract][Full Text] [Related]
12. In vitro release of hypothalamic beta-endorphin (beta E) by arginine vasopressin, corticotropin-releasing hormone and 5-hydroxytryptamine: evidence for release of opioid active and inactive beta E forms.
Bronstein DM; Akil H
Neuropeptides; 1990 May; 16(1):33-40. PubMed ID: 2250765
[TBL] [Abstract][Full Text] [Related]
13. Involvement of corticotropin-releasing hormone and endogenous opioid peptides in prolactin-suppressed gonadotropin-releasing hormone release in vitro.
Calogero AE; Weber RF; Raiti F; Burrello N; Moncada ML; Mongioì A; D'Agata R
Neuroendocrinology; 1994 Sep; 60(3):291-6. PubMed ID: 7969787
[TBL] [Abstract][Full Text] [Related]
14. Multiple factors influencing the in vitro release of [Met5]-enkephalin from rat hypothalamic slices.
Nikolarakis KE; Almeida OF; Herz A
J Neurochem; 1989 Feb; 52(2):428-32. PubMed ID: 2783452
[TBL] [Abstract][Full Text] [Related]
15. In vitro-perifused rat testes secrete beta-endorphin and dynorphin: their effect on testosterone secretion.
Margioris AN; Koukoulis G; Grino M; Chrousos GP
Biol Reprod; 1989 Apr; 40(4):776-84. PubMed ID: 2568857
[TBL] [Abstract][Full Text] [Related]
16. Effects of luteinizing-hormone-releasing hormone, alpha-melanocyte-stimulating hormone, naloxone, dexamethasone and indomethacin on interleukin-2-induced corticotropin-releasing factor release.
Karanth S; Lyson K; Aguila MC; McCann SM
Neuroimmunomodulation; 1995; 2(3):166-73. PubMed ID: 8646567
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of LH release by CRF may be partially mediated through hypothalamic beta-endorphin release.
Nikolarakis KE; Almeida OF; Herz A
NIDA Res Monogr; 1986; 75():403-5. PubMed ID: 2963219
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue.
Schäfer M; Carter L; Stein C
Proc Natl Acad Sci U S A; 1994 May; 91(10):4219-23. PubMed ID: 7910403
[TBL] [Abstract][Full Text] [Related]
19. A two-step mechanism by which corticotropin-releasing hormone releases hypothalamic beta-endorphin: the role of vasopressin and G-proteins.
Burns G; Almeida OF; Passarelli F; Herz A
Endocrinology; 1989 Sep; 125(3):1365-72. PubMed ID: 2527150
[TBL] [Abstract][Full Text] [Related]
20. Stimulation and inhibition of corticotrophin releasing factor secretion by beta endorphin.
Buckingham JC
Neuroendocrinology; 1986; 42(2):148-52. PubMed ID: 2936971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
